About this Course

Jointly provided by Postgraduate Institute for Medicine and Parkinson & Movement Disorder Alliance

Release date: October 23, 2021

Expiration date: October 23, 2023

Estimated time to complete activity: 4.5 hours


Target Audience

This activity is intended for clinicians engaged in the care of patients with Parkinson’s and other Movement Disorders.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Identify motor and non-motor treatments in movement and related disorders and their effects on patient quality of life.
  • Utilize patient questionnaires and interview questions during the clinic visit to assess patient’s symptoms from movement and related disorders.
  • Evaluate nonmotor symptoms in Parkinson’s and related disorders including cognitive issues and sialorrhea.
  • Prescribe appropriate therapies to mitigate a multitude of motor and non-motor symptoms and improve patient outcomes.
  • Manage the calculation of dose, titration, and effective programming of devices as appropriate.


Fernando L. Pagán, MD
MedStar Georgetown University Hospital
Medical Director of Georgetown University Hospital
Director of Movement Disorders Program
Professor and Vice Chairman of Neurology

Yasar Torres-Yaghi, MD
MedStar Georgetown University Hospital
Director of the Parkinsonism and Dementia Clinic
Assistant Professor of Neurology

Elizabeth Epstein Mundel, MD
Medstar Georgetown University Hospital
Assistant Professor of Neurology

Dr. Laxman Bahroo, DO
Medstar Georgetown University Hospital
Vice Chair of Finance
Director, Residency Program
Director, Botulinum Toxin Clinic
Associate Professor of Neurology

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Fernando L. Pagán, MD – Consulting Fees – Acorda, Amneal, Abbvie, Adamas, Kyowa Kirin, Merz, Lundbeck, Neurocrine, Sunovion, Supernus, Teva, US World Meds – Fees for Non-CE Services – Acorda, Amneal, Abbvie, Adamas, Kyowa Kirin, Merz, Neurocrine, Sunovion, Supernus, Teva, US World Meds – Contracted Research – Sun Pharma, US World Meds, Kyowa Kirin – Ownership Interest – Keiferx LLC – Other – Co-Founder and Board Member Keiferx LLC

Yasar Torres-Yaghi, MD – IP/Patent Holder – Mindsquare Technology – Consulting Fees – Abbvie, Acorda, Amneal, Acadia, Abbott, Sunovion, Teva, US World Meds, Biogen

Elizabeth Epstein Mundel, MD has nothing to disclose

Dr. Laxman Bahroo, DO, MS – Consulting Fees – Abbvie, Acadia, Acorda, Adamas, Amneal, Britannia, Ipsen Biopharma, Jazz Pharmaceuticals, Kyowa Kirin, Neurocrine, Revance, Supernus and Sunovion

The PIM planners and others have nothing to disclose. The PMD Alliance planners and others have nothing to disclose.

Joint Accreditation Statement 

Jointly%20Accredited%20Provider%20TMIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PMD Alliance.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 4.5 contact hours.    

Computer System Requirements

A smartphone, tablet, or computer with access to the internet.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation and Request for Credit

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

  1. Go to www.cmeuniversity.com  
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. While logged in, go to https://www.cmeuniversity.com/course/take/122056
  4. Choose the type of credit you desire
  5. Complete the online Evaluation
  6. Receive an immediate CE Certificate to download and/or print for your files

If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com or PMD Alliance at education@pmdalliance.org 


Fernando L. Pagan, MD

Movement Disorder Specialist

Fernando L. Pagan, MD is a board-certified neurologist and Professor and Vice Chairman for the Department of Neurology at MedStar Georgetown University Hospital in Washington DC. He is the Director of the Movement Disorders Program and the Medical Director of MedStar Georgetown's National Parkinson Foundation Center of Excellence, as well as the Fellowship Director for the clinical research done at the Movement Disorders Fellowship at MedStar Georgetown. He also serves as the Medical Director of the Translational Neuroscience Program (TNP). He is a member of the Functional Neurosurgery Team for Movement Disorders, performing preoperative evaluations and programming for deep brain stimulators in Parkinson disease, essential tremor and dystonia. After receiving his medical degree from Georgetown University and completing an internal medicine internship and neurology residency at MedStar Georgetown, he completed a fellowship in movement disorders and magnetic resonance spectroscopy at the National Institute of Neurological Diseases and Stroke within the National Institutes of Health. His special interests include Parkinson disease, parkinsonism and other related disorders, ataxia, essential tremor, dystonia, and tics. He is an expert in botulinum toxin treatment for dystonia, tremor, spasticity, and tics.

Yasar Torres-Yaghi, MD

Movement Disorder Specialist

Yasar Torres Yaghi, MD is a board-certified neurologist at the MedStar Georgetown University Hospital in Washington, DC and Co-Director of the Lewy Body Dementia Clinic. He obtained his medical degree from George Washington University School of Medicine, and subsequently completed his residency and fellowship training at MedStar Georgetown University Hospital. In his role as a movement disorder specialist, he is spearheading an initiative to care for the growing population of aging patients with neurodegenerative conditions characterized by overlapping features of both cognitive impairment and Parkinson’s. His research focus is in neurodegeneration and movement disorders such as Lewy body dementia and Parkinson disease. Additionally, he evaluates patients with Alzheimer’s disease, chronic traumatic encephalopathy, and Huntington disease. In addition to caring for patients in clinic and teaching medical students, his goal has been a career in combining research and clinical work.


Elizabeth Mundel, MD

Movement Disorder Specialist

Attending Physician, Movement Disorders Assistant Professor, Department of Neurology Specialties: Neurology, Movement Disorders Medical School: Georgetown University School of Medicine, 2013 Internship: St. Lukes - Roosevelt Hospital Center, 2014 Residency: MedStar Georgetown University Hospital, 2017 Fellowship: Movement Disorders, MedStar Georgetown University Hospital, 2019 Certifications: American Board of Psychiatry and Neurology

Laxman Bahroo, DO, MS

Movement Disorder Specialist

Laxman Bahroo, DO, MS is a board-certified neurologist and movement disorder specialist. He is Director of both the Neurology Residency Program and Botulinum Toxin Clinic at Georgetown University Medical Center in Washington, DC. He is also an associate professor at the Georgetown University Department of Neurology. After receiving his medical degree at the University of Medicine and Dentistry of New Jersey, he completed his residency and fellowship at the Georgetown University Hospital. His primary areas of focus include the medical and surgical management of Parkinson disease and essential tremor. He also specializes in therapeutic botulinum toxin injections for dystonia, spasticity and sialorrhea.

Course Reviews and Ratings

5 star rating

The course seemed to be well organized but it dd not come to any conclusions.

Donald Weir

5 star rating

Not Your Grandmother's Dopamine: Foundations of Advanced Therapeutics in Movement and Related Disorders

Barbara Wilmarth

Excellent talk

Excellent talk

Read Less